BackAxsome Therapeutics Overview
Axsome Therapeutics Inc

Axsome Therapeutics Target Price

Analysts' 12-month price predictions for AXSM.

Share Price

$103.36

Average Target Price

$179.3373.5% upside

3 analysts in the last 4 months

High: $216 | Low: $160

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2025-05-06Robert W. BairdJoel Beatty$16256.7% upsideOpen
2025-03-27Mizuho SecuritiesGraig Suvannavejh$216109% upsideOpen
2025-03-03Robert W. Baird$16054.8% upsideOpen
2025-02-03Mizuho SecuritiesGraig Suvannavejh$13732.5% upsideOpen
2025-02-03Truist FinancialJoon Lee$19083.8% upsideOpen
2025-02-03Robert W. BairdJoel Beatty$13227.7% upsideOpen
2024-11-12GuggenheimYatin Suneja$13530.6% upsideOpen
2024-09-11Mizuho SecuritiesGraig Suvannavejh$1062.6% upsideOpen
2024-09-03Wells FargoCerena Chen$14035.4% upsideOpen
2024-08-06H.C. WainwrightRaghuram Selvaraju$18074.1% upsideOpen
2024-08-06Bank of America SecuritiesJason Gerberry$1062.6% upsideOpen
2024-07-22RBC CapitalLeonid Timashev$13126.7% upsideOpen
2024-06-05RBC CapitalLeonid Timashev$13025.8% upsideOpen
2024-05-28Piper SandlerDavid Amsellem$11511.3% upsideOpen
2024-04-29Morgan StanleyVikram Purohit$11511.3% upsideOpen
2024-03-28Mizuho SecuritiesGraig Suvannavejh$1095.5% upsideOpen
2024-03-18Robert W. BairdJoel Beatty$1084.5% upsideOpen
2023-01-05Piper Sandler$7527.4% downsideOpen
2022-12-23BTIGRobert Hazlett$985.2% downsideOpen
2022-11-29Morgan Stanley$8616.8% downsideOpen
2022-11-29Leerink Partners$8517.8% downsideOpen
2022-11-11Guggenheim$8022.6% downsideOpen
2022-08-19Truist FinancialJoon Lee$15045.1% upsideOpen
2022-05-03Mizuho Securities$4952.6% downsideOpen
2022-04-27Morgan Stanley$2773.9% downsideOpen
2022-03-01Truist FinancialJoon Lee$9012.9% downsideOpen
2021-08-10Bank of America SecuritiesAshwani Verma$2575.8% downsideOpen